GLP-1 Medications Shift Consumer Expectations in Food and Drink
The increasing adoption of GLP-1 medications, originally developed for diabetes and later used for weight loss, has become a key factor in shaping consumer behavior in the food and beverage sectors. According to Tate & Lyle's global marketing director, Marina Migueli, this phenomenon is redefining perceptions of food and health, with a significant influence on what is considered as better-for-you options.
Changing Consumer Preferences
Research indicates that the global full-time use of GLP-1 medications could reach between 103 million and 485 million adults by 2030. This rise is driving consumers to seek foods that combine comfort with nutritional function, placing a strong emphasis on mouthfeel in products as part of an intentional eating experience. Items such as creamy shakes and crispy snacks are gaining popularity due to their satisfying texture and nutritional benefits.
Among the user groups influenced by GLP-1 medications are those currently using the drugs, former users, and health-conscious non-users. All these groups are united by their interest in nutritious foods that do not compromise on taste, utilizing high-protein, fiber-rich products with clean labels.
Food Formulation Strategies
Brands are focusing on mastering mouthfeel to attract and retain consumers who now eat with more intention. Innovations in ingredient systems aim to replicate the sensory cues traditionally provided by sugar or fat, using fiber, starches, and pectin to enhance texture and nutritional profiles.
For active GLP-1 users, the reduced appetite means smaller meal portions where each bite matters more. Smooth, creamy textures in functional shakes, for example, are highly preferred, with 40% of users indicating a desire for less artificial-feeling textures.
Former users transitioning off GLP-1 medications are concerned with maintaining satiety and nutrition without the medication's support. Research shows that they often revert to previous eating patterns if better-for-you options do not meet expectations in taste and texture. This presents an opportunity for food brands to cater to these needs by delivering satisfying and nutritionally balanced products.
In addition, health-conscious non-users also emphasize the importance of mouthfeel, where texture and nutrition work together to quell appetite and support healthy habits.
Conclusion
Overall, GLP-1 medications are significantly altering the discourse around nourishment, requiring food and drink to fulfill diverse physical, nutritional, and emotional needs. Companies are urged to innovate by focusing on how their products taste and feel to redefine modern dietary experiences effectively.
